Skip to main content

Saxitoxin

ADVERTISEMENT
Identification
Molecular formula
C10H17N7O4
CAS number
35523-89-8
IUPAC name
3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one
State
State

At room temperature, Saxitoxin is typically found in its solid state. It is stable under normal conditions as a crystalline solid.

Melting point (Celsius)
200.00
Melting point (Kelvin)
473.15
Boiling point (Celsius)
760.00
Boiling point (Kelvin)
1 033.15
General information
Molecular weight
299.28g/mol
Molar mass
299.1080g/mol
Density
1.5000g/cm3
Appearence

Saxitoxin typically appears as a white, crystalline powder when isolated in its pure form. It is often synthesized and used in laboratory settings due to its potent properties.

Comment on solubility

Solubility of 3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one

The solubility of the compound 3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one (C10H17N7O4) can be influenced by a variety of factors due to its complex structure. Some key points to consider regarding its solubility include:

  • Polarity: The presence of nitrogen and oxygen atoms suggests moderate polarity, which can affect solubility in polar solvents like water.
  • Solvent Compatibility: Likely more soluble in organic solvents such as ethanol or acetone compared to water due to its hydrophobic characteristics.
  • Structural Complexity: The intricate cyclic structure may hinder solubility, particularly in less polar solvents.
  • Hydrogen Bonding: The ability of the compound to engage in hydrogen bonding can enhance solubility in certain polar solvents.

As a rule of thumb, "like dissolves like," meaning that the solubility will generally be favorable in environments that are similar to the compound's inherent properties. Overall, while specific quantitative solubility data may be scarce, it is clear that the intricate nature of this compound significantly plays a role in determining its solubility profile.

Interesting facts

Exploring 3,13,23-Triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one

This fascinating compound, formally known as 3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one, presents a unique set of characteristics due to its complex structure and intricate arrangement of nitrogen and carbon atoms. Here are some compelling insights into this intriguing chemical:

  • Cyclization: The compound showcases a highly cyclized structure, which can lead to interesting chemical behavior and reactivity. Cyclization plays a crucial role in determining the stability and functions of many organic compounds.
  • Azole Presence: With three nitrogen atoms incorporated into its structure, it offers properties typical of azole compounds, which are significant in the fields of pharmaceuticals and agrochemicals.
  • Potential Applications: Owing to its structural complexity, derivatives of this compound could potentially serve as advanced materials or in drug discovery, specifically in targeting viral or bacterial infections.
  • Research Interest: Chemists are continuously exploring cyclic compounds with nitrogen to unlock their unique reactivity and biological functions, making this compound a potential focal point for future research.

As expressed by renowned chemist Marie Curie, “Nothing in life is to be feared; it is only to be understood.” Understanding compounds like this could unlock new avenues in science and technology.

The intricate balance of carbon, nitrogen, and oxygen within this compound reinforces its potential significance in organic chemistry and invites further investigation into its properties and applications. Scientists remain motivated to decode the complexities embedded within such unique chemical structures.

Synonyms
K-252c
85753-43-1
Staurosporine aglycone
K252C
6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one
staurosporinone
HAJ5XS5HPF
K-252c; Staurosporinone
STAUROSPORINE AGLYCON
CHEMBL16958
6,7,12,13-Tetrahydro-5H-indolo-[2,3-a]pyrrolo[3,4-c]carbazol-5-one
SD-1825
5H-Indolo(2,3-a)pyrrolo(3,4-C)carbazol-5-one, 6,7,12,13-tetrahydro-
5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one, 6,7,12,13-tetrahydro-
6,7,12,13-Tetrahydro-5H-indolo(2,3-a)pyrrolo(3,4-C)carbazol-5-one
3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one
UNII-HAJ5XS5HPF
CBiol_002017
BDBM2581
K252c; Staurosporine Aglycone
SCHEMBL5440281
Staurosporine aglycone, >=95%
C20H13N3O
CHEBI:204201
MEXUTNIFSHFQRG-UHFFFAOYSA-N
Bio1_000303
Bio1_000792
Bio1_001281
DTXSID801017989
HMS3261B05
HMS3674I19
HY-N6736
Tox21_500482
HB0353
HSCI1_000357
AKOS024457029
BS-1317
CCG-221786
DB08036
LP00482
SDCCGSBI-0633718.P001
NCGC00167955-01
NCGC00167955-02
NCGC00261167-01
BK162734
DA-64684
CS-0029278
NS00069049
C21126
G12520
K00232
K-252c - CAS 85753-43-1
BRD-K93879806-001-01-4
Q27097269
2,3,8,9-tetrahydro-1H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-1-one
6,7,12,13-tetrahydro-5-oxo-5H-indolo[2.3-a]pyrrolo [3,4-c]carbazole
3,13,23-triazahexacyclo[14.7.0.0(2),(1)?.0?,?.0(1)(1),(1)?.0(1)?,(2)(2)]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-12-one
3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-12-one
6,7,12,13-Tetrahydro-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one; Antibiotic K 252c; SD 1825; Staurosporine Aglycon; Staurosporinone
632-917-2